Cleveland BioLabs Inc.

News and FDA Updates for Cleveland BioLabs (NASDAQ:CBLI), CTD (OTC:CTDH), Enzon (Nasdaq:ENZN).
M2 Presswire; 12/23/2009; 905 words; ...2009-BiomedReports: News and FDA Updates for Cleveland BioLabs (NASDAQ:CBLI), CTD (OTC:CTDH), Enzon...found on BioMedReports.Com On 12/22/09, Cleveland BioLabs, Inc. (NASDAQ:CBLI) issued a statement from its...

CLEVELAND BIOLABS REPORTS MULTIPLE TRANSACTIONS BY SECRETARY KOGAN (New York)
US Fed News Service, Including US State News; 12/3/2009; 297 words; WASHINGTON, Dec. 3 -- Cleveland Biolabs Inc. (CBLI), Buffalo, N.Y., has filed a Form 4 with the Securities and Exchange Commission noting the change in the beneficial...

Terapio: $5M Round 'Transports' ARS, Skin Protein Toward Clinic.
BIOWORLD Today; 12/1/2009; 1452 words; ...Services rejected Hollis-Eden Pharmaceuticals Inc.'s Neumune and cancelled an ARS request for...space has no shortage of players, including Cleveland BioLabs Inc., Aeolus Pharmaceuticals Inc., ImmuneRegen BioSciences Inc., Osiris Therapeutics...

Publication No. WO/2009/143290 Published on Nov. 26, Assigned to Cleveland Biolabs, Inc, Roswell Park Cancer Institute for Inducing Cell Death By Inhibiting Adaptive Heat Shock Response (American Inventors)
US Fed News Service, Including US State News; 11/30/2009; 407 words; ...have developed a inducing cell death by inhibiting adaptive heat shock response. The patent has been assigned to Cleveland Biolabs, Inc, City, United States Of America, and Roswell Park Cancer Institute, City, United States Of America. According...

Clinic Roundup.
BIOWORLD Today; 11/24/2009; 1842 words; ...insulin in diabetic patients. o Cleveland BioLabs Inc., of Buffalo, N.Y., started...vaccination. o DARA BioSciences Inc., of Raleigh, N.C., reported...dysfunction. o Human Genome Sciences Inc., of Rockville, Md., and Aegera...